{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1980-N-0038\" and posted_year = 2018 sorted by posted_date descending", "rows": [["FDA-1980-N-0038-0628", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.4 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:26Z", null, 0, 0, "0900006482d144e9"], ["FDA-1980-N-0038-0625", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.14 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:26Z", null, 0, 0, "0900006482d14a2a"], ["FDA-1980-N-0038-0621", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.7 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:24Z", null, 0, 0, "0900006482d14b04"], ["FDA-1980-N-0038-0600", "FDA", "FDA-1980-N-0038", "Iodochlorhydroxyquin re: Supplement from Hyrex Pharmaceuticals", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:02:52Z", null, 0, 0, "0900006482ceae37"], ["FDA-1980-N-0038-0643", "FDA", "FDA-1980-N-0038", "EXHIBIT C-6.1 - Amendment to New Drug Application Locorten 0.02% w/Vioform 3% Cream NDA 16-380 - 12-30-71", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:32Z", null, 0, 0, "0900006482cf3977"], ["FDA-1980-N-0038-0618", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.8 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:23Z", null, 0, 0, "0900006482d14c51"], ["FDA-1980-N-0038-0613", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.9 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:21Z", null, 0, 0, "0900006482d15dfd"], ["FDA-1980-N-0038-0601", "FDA", "FDA-1980-N-0038", "Reference of Memorandum from FDA", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2020-01-31T06:55:56Z", null, 0, 0, "0900006482cefd57"], ["FDA-1980-N-0038-0641", "FDA", "FDA-1980-N-0038", "EXHIBIT C-13.1: Submission of Data, Information, Analyses, and Views in Support of the Request for Hearing for Neo-Synalar Cream (NDA 60-700)", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:30Z", null, 0, 0, "0900006482cfbb34"], ["FDA-1980-N-0038-0639", "FDA", "FDA-1980-N-0038", "EXHIBIT C-1.2 - Appendix to Request for Hearing of CIBA-GEIGY Corp. - 11-24-81", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:29Z", null, 0, 0, "0900006482d09560"], ["FDA-1980-N-0038-0614", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.8 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:21Z", null, 0, 0, "0900006482d15b0b"], ["FDA-1980-N-0038-0617", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.9 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:23Z", null, 0, 0, "0900006482d14c55"], ["FDA-1980-N-0038-0624", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.6 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:25Z", null, 0, 0, "0900006482d14e9c"], ["FDA-1980-N-0038-0644", "FDA", "FDA-1980-N-0038", "Comment from Byk-Gulden, Inc.", "Other", "Letter(s)", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:19:39Z", null, 0, 0, "0900006482cf7721"], ["FDA-1980-N-0038-0620", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.2 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:23Z", null, 0, 0, "0900006482d14b97"], ["FDA-1980-N-0038-0616", "FDA", "FDA-1980-N-0038", "EXHIBITS C-13.3, C-13.4, C-13.5, C-13.6, C-13.7, C-15.1, C-15.2 & C-15.3", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:22Z", null, 0, 0, "0900006482d1508b"], ["FDA-1980-N-0038-0609", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.11 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:20Z", null, 0, 0, "0900006482d161d7"], ["FDA-1980-N-0038-0599", "FDA", "FDA-1980-N-0038", "Certificate of Service re: Request for Hearing from Premo Pharmaceutical Laboratories, Inc. (Hamel, Park, McCabe & Saunders)", "Other", "Certificate of Service", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:01:50Z", null, 0, 0, "0900006482ce8a55"], ["FDA-1980-N-0038-0594", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T15:50:10Z", null, 0, 0, "09000064805b96d6"], ["FDA-1980-N-0038-0631", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.11 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:27Z", null, 0, 0, "0900006482d14387"], ["FDA-1980-N-0038-0637", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.2 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:29Z", null, 0, 0, "0900006482d13400"], ["FDA-1980-N-0038-0615", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.5 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:22Z", null, 0, 0, "0900006482d1581a"], ["FDA-1980-N-0038-0635", "FDA", "FDA-1980-N-0038", "EXHIBIT C-13.2: Submission of Data, Information, Analyses, and Views in Support of the Request for Hearing for Neo-Synalar Cream (NDA 60-700)", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2020-01-31T06:55:57Z", null, 0, 0, "0900006482d13df0"], ["FDA-1980-N-0038-0619", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.7 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:23Z", null, 0, 0, "0900006482d14b98"], ["FDA-1980-N-0038-0623", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.15 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:25Z", null, 0, 0, "0900006482d14ec3"], ["FDA-1980-N-0038-0608", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.14 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:19Z", null, 0, 0, "0900006482d165cc"], ["FDA-1980-N-0038-0602", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.13 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:15Z", null, 0, 0, "0900006482d33ffc"], ["FDA-1980-N-0038-0603", "FDA", "FDA-1980-N-0038", "EXHIBITS G-81 thru G-85: Supplemental/Written Direct Testimony", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:17Z", null, 0, 0, "0900006482d33959"], ["FDA-1980-N-0038-0610", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.10 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:20Z", null, 0, 0, "0900006482d161d6"], ["FDA-1980-N-0038-0612", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.12 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:20Z", null, 0, 0, "0900006482d15bc7"], ["FDA-1980-N-0038-0611", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.6 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:20Z", null, 0, 0, "0900006482d15bc8"], ["FDA-1980-N-0038-0595", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T15:57:24Z", null, 0, 0, "09000064805b9744"], ["FDA-1980-N-0038-0640", "FDA", "FDA-1980-N-0038", "EXHIBIT C-2 - The American Academy of Dermatology's Comments on the Availability of Topical Anti-Infective Combinations and Steroid Anti-Infective Combinations", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:30Z", null, 0, 0, "0900006482cfbb35"], ["FDA-1980-N-0038-0645", "FDA", "FDA-1980-N-0038", "Exhibit AAD-1 - Written and Direct Testimony of Peyton E. Weary, M.D. and Exhibit AAD-2 - Testimony of James J. Leyden, M.D.", "Supporting & Related Material", "Testimony", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:20:03Z", null, 0, 0, "0900006482cf8410"], ["FDA-1980-N-0038-0634", "FDA", "FDA-1980-N-0038", "EXHIBITS C-16, C-17, C-18: Supplemental and Additional Analyses of Carpenter, Brecker and Vioform-Locorten Studies", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:28Z", null, 0, 0, "0900006482d134f6"], ["FDA-1980-N-0038-0636", "FDA", "FDA-1980-N-0038", "EXHIBITS C-20 thru C-28: Written Evidence of CIBA-GEIGY Corporation", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:29Z", null, 0, 0, "0900006482d13404"], ["FDA-1980-N-0038-0596", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T15:58:02Z", null, 0, 0, "09000064805b9745"], ["FDA-1980-N-0038-0622", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.4 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:25Z", null, 0, 0, "0900006482d14830"], ["FDA-1980-N-0038-0633", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.10 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2020-01-31T06:55:57Z", null, 0, 0, "0900006482d14537"], ["FDA-1980-N-0038-0626", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.5 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:26Z", null, 0, 0, "0900006482d14a26"], ["FDA-1980-N-0038-0606", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.15 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:18Z", null, 0, 0, "0900006482d165cf"], ["FDA-1980-N-0038-0605", "FDA", "FDA-1980-N-0038", "EXHIBITS G-76 thru G-78: Written Direct Testimony", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:18Z", null, 0, 0, "0900006482d32294"], ["FDA-1980-N-0038-0598", "FDA", "FDA-1980-N-0038", "Motion of the Center for Drugs and Biologics to Strike Exhibit C-29", "Other", "Motion", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:00:17Z", null, 0, 0, "09000064805b9767"], ["FDA-1980-N-0038-0627", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.3 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:26Z", null, 0, 0, "0900006482d1482b"], ["FDA-1980-N-0038-0630", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.12 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:27Z", null, 0, 0, "0900006482d143ed"], ["FDA-1980-N-0038-0632", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.3 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:28Z", null, 0, 0, "0900006482d142d9"], ["FDA-1980-N-0038-0629", "FDA", "FDA-1980-N-0038", "EXHIBIT G-2.13 - Patient report forms from Carpenter Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:27Z", null, 0, 0, "0900006482d1483d"], ["FDA-1980-N-0038-0607", "FDA", "FDA-1980-N-0038", "EXHIBIT G-4.16 - Patient report forms from Brecker Study", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:19Z", null, 0, 0, "0900006482d314ba"], ["FDA-1980-N-0038-0593", "FDA", "FDA-1980-N-0038", "Order of Ciba-Geigy from FDA", "Other", "Order", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T15:48:29Z", null, 0, 0, "09000064805b96aa"], ["FDA-1980-N-0038-0597", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-02-14T05:00:00Z", 2018, 2, "2018-02-14T05:00:00Z", null, "2018-02-14T15:58:55Z", null, 0, 0, "09000064805b974a"], ["FDA-1980-N-0038-0642", "FDA", "FDA-1980-N-0038", "EXHIBIT C-7 - E.A. Konopka, Et Al., \"Antimicrobial Effectiveness of Locacorten-Vioform Cream in Secondary Infections of Common Dermatoses - 1-8-75\nEXHIBIT C-8 - Richard C.M. Miller, M.D., \"Flumethasone Pivalate-Iodochlorhydroxyquin Cream: A New Corticosteroid Anti-Infective Combination.\" - 10-1-74\nEXHIBIT C-10.3 - Federal Register Notice - 3-23-82\nEXHIBIT C-11 - Federal Register Notice - 3-28-84", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:31Z", null, 0, 0, "0900006482cf3dcb"], ["FDA-1980-N-0038-0604", "FDA", "FDA-1980-N-0038", "EXHIBIT C-14.14: FDA Medical Review and Evaluation of Vioform-Hydrocortisone Cream (undated\u2014initiated by E. Tabor 7/15/85) \nEXHIBIT C-14.15: DA Statistical review and evaluation of Vioform-Hydrocortisone (dated July 9, 1985)", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:18Z", null, 0, 0, "0900006482d3271b"], ["FDA-1980-N-0038-0638", "FDA", "FDA-1980-N-0038", "EXHIBITS C-14.1, C-14.2, C-14.3, C-14.7: FDA medical and statistical reviews of Vioform- Hydrocortisone and of 1982 AAD submission", "Supporting & Related Material", "Background Material", "2018-02-14T05:00:00Z", 2018, 2, null, null, "2018-02-14T16:17:29Z", null, 0, 0, "0900006482d133b0"], ["FDA-1980-N-0038-0577", "FDA", "FDA-1980-N-0038", "Request for Exceptions from Clay-Park Labs, Inc. Hyrex Pharmaceuticals, Mallard, Inc., Maynard, Inc. MNC Laboratories, Inc., National Pharmaceutical Alliance and UAD Laboratories, Inc.", "Other", "Exception/Waiver", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:43:18Z", null, 0, 0, "09000064805b9786"], ["FDA-1980-N-0038-0575", "FDA", "FDA-1980-N-0038", "Memorandum to the Record from FDA/DDM", "Other", "Memorandum", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:42:14Z", null, 0, 0, "09000064805b9784"], ["FDA-1980-N-0038-0579", "FDA", "FDA-1980-N-0038", "Exceptions of CIBA-GEIGY Corporation to Initial Decision and Brief in Support of Exceptions (Sutherland, Asbill & Brennan)", "Other", "Exception/Waiver", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:44:31Z", null, 0, 0, "09000064805b9788"], ["FDA-1980-N-0038-0584", "FDA", "FDA-1980-N-0038", "Memorandum of Separation of Functions from Thomas Scarlett", "Other", "Separation of Functions", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:48:13Z", null, 0, 0, "09000064805b978f"], ["FDA-1980-N-0038-0583", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:47:47Z", null, 0, 0, "09000064805b978e"], ["FDA-1980-N-0038-0572", "FDA", "FDA-1980-N-0038", "Order from FDA", "Other", "Order", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:13:50Z", null, 0, 0, "09000064805b9780"], ["FDA-1980-N-0038-0586", "FDA", "FDA-1980-N-0038", "Certificate of Service re: Correction from FDA CDER", "Other", "Certificate of Service", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2020-01-31T06:55:56Z", null, 0, 0, "0900006482ce99fb"], ["FDA-1980-N-0038-0587", "FDA", "FDA-1980-N-0038", "Reply to Ciba-Geigy's Exceptions From FDA/CDER", "Other", "Reply", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:58:27Z", null, 0, 0, "09000064805b9791"], ["FDA-1980-N-0038-0581", "FDA", "FDA-1980-N-0038", "Request for Extension from FDA/CDER", "Other", "Request for Extension", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:46:47Z", null, 0, 0, "09000064805b978b"], ["FDA-1980-N-0038-0578", "FDA", "FDA-1980-N-0038", "Request for Exceptions from Lemmon Company", "Other", "Exception/Waiver", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:44:03Z", null, 0, 0, "09000064805b9787"], ["FDA-1980-N-0038-0585", "FDA", "FDA-1980-N-0038", "Correction from FDA CDER", "Other", "Correction(s)", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:48:58Z", null, 0, 0, "09000064805b9790"], ["FDA-1980-N-0038-0573", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:26:03Z", null, 0, 0, "09000064805b9781"], ["FDA-1980-N-0038-0591", "FDA", "FDA-1980-N-0038", "Memorandum of Separation of Functions from FDA", "Other", "Separation of Functions", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T15:07:44Z", null, 0, 0, "09000064805b9797"], ["FDA-1980-N-0038-0589", "FDA", "FDA-1980-N-0038", "Memorandum of  Separation of Function from FDA", "Other", "Separation of Functions", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T15:06:05Z", null, 0, 0, "09000064805b9795"], ["FDA-1980-N-0038-0590", "FDA", "FDA-1980-N-0038", "Memorandum of Separation of Functions from FDA", "Other", "Separation of Functions", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T15:07:14Z", null, 0, 0, "09000064805b9796"], ["FDA-1980-N-0038-0582", "FDA", "FDA-1980-N-0038", "Order from FDA/CDER", "Other", "Order", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:47:25Z", null, 0, 0, "09000064805b978c"], ["FDA-1980-N-0038-0576", "FDA", "FDA-1980-N-0038", "Request for Exception from Dermik Laboratories", "Other", "Exception/Waiver", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:42:50Z", null, 0, 0, "09000064805b9785"], ["FDA-1980-N-0038-0592", "FDA", "FDA-1980-N-0038", "Memorandum of Separation of Functions from FDA", "Other", "Separation of Functions", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T15:08:05Z", null, 0, 0, "09000064805b9798"], ["FDA-1980-N-0038-0588", "FDA", "FDA-1980-N-0038", "Reply Brief for Ciba-Geigy Corporation in Support of Exceptions to Initial Decision", "Other", "Reply", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:58:52Z", null, 0, 0, "09000064805b9794"], ["FDA-1980-N-0038-0580", "FDA", "FDA-1980-N-0038", "Correction from Lemmon Company (Kleinfeld, Kaplan and Becker)", "Other", "Correction(s)", "2018-02-01T05:00:00Z", 2018, 2, null, null, "2018-02-01T14:45:35Z", null, 0, 0, "09000064805b978a"], ["FDA-1980-N-0038-0566", "FDA", "FDA-1980-N-0038", "List from Ciba-Geigy Corporation, et al", "Other", "List (LST)", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T15:59:37Z", null, 0, 0, "09000064805b9779"], ["FDA-1980-N-0038-0561", "FDA", "FDA-1980-N-0038", "Briefing Material from Dermik Laboratories, Inc. and The Byk Group", "Other", "Brief", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:50:02Z", null, 0, 0, "09000064805b9774"], ["FDA-1980-N-0038-0570", "FDA", "FDA-1980-N-0038", "Request for Extension from Ciba-Geigy Corporation", "Other", "Request for Extension", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-02-02T02:03:00Z", null, 0, 0, "09000064805b977e"], ["FDA-1980-N-0038-0560", "FDA", "FDA-1980-N-0038", "Certificate of Service re: Findings of Fact from Ciba-Geigy Corporation (Sutherland, Asbill & Brennan)", "Other", "Certificate of Service", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:32:10Z", null, 0, 0, "0900006482d09703"], ["FDA-1980-N-0038-0568", "FDA", "FDA-1980-N-0038", "Initial Decision by Admin. Law Judge from FDA", "Other", "Initial Decision", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T16:01:02Z", null, 0, 0, "0900006482d09f62"], ["FDA-1980-N-0038-0564", "FDA", "FDA-1980-N-0038", "Finding of Facts from Clay-Park Labs, Inc., et al", "Other", "Findings of Fact", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T15:46:56Z", null, 0, 0, "09000064805b9777"], ["FDA-1980-N-0038-0557", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:30:39Z", null, 0, 0, "09000064805b979a"], ["FDA-1980-N-0038-0559", "FDA", "FDA-1980-N-0038", "Findings of Fact from Ciba-Geigy Corporation (Sutherland, Asbill & Brennan)", "Other", "Findings of Fact", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:31:51Z", null, 0, 0, "09000064805b9772"], ["FDA-1980-N-0038-0565", "FDA", "FDA-1980-N-0038", "Post-Hearing Brief of the Center for Drugs and Biologics", "Other", "Brief", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2020-01-31T06:55:42Z", null, 0, 0, "09000064805b9778"], ["FDA-1980-N-0038-0563", "FDA", "FDA-1980-N-0038", "Briefing Material from Clay-Park Labs, Inc. et al", "Other", "Brief", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T15:25:53Z", null, 0, 0, "09000064805b9776"], ["FDA-1980-N-0038-0562", "FDA", "FDA-1980-N-0038", "Briefing Material from Lemmon Company", "Other", "Brief", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T15:25:20Z", null, 0, 0, "09000064805b9775"], ["FDA-1980-N-0038-0556", "FDA", "FDA-1980-N-0038", "Stipulation from FDA CDER and Ciba-Geigy Corporation", "Other", "Stipulation(s)", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:08:11Z", null, 0, 0, "09000064805b9770"], ["FDA-1980-N-0038-0558", "FDA", "FDA-1980-N-0038", "Post-Hearing Brief For Ciba-Geigy Corporation (Sutherland, Asbill & Brennan)", "Other", "Brief", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T14:31:12Z", null, 0, 0, "09000064805b9771"], ["FDA-1980-N-0038-0567", "FDA", "FDA-1980-N-0038", "Reply to Motion from Ciba-Geigy Corporation", "Other", "Reply", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T16:00:26Z", null, 0, 0, "09000064805b977a"], ["FDA-1980-N-0038-0569", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T16:02:24Z", null, 0, 0, "09000064805b977c"], ["FDA-1980-N-0038-0571", "FDA", "FDA-1980-N-0038", "Reply Comment from FDA CDER", "Other", "Reply Comments", "2018-01-31T05:00:00Z", 2018, 1, null, null, "2018-01-31T20:08:44Z", null, 0, 0, "09000064805b977f"], ["FDA-1980-N-0038-0550", "FDA", "FDA-1980-N-0038", "Order from FDA", "Other", "Order", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:42:11Z", null, 0, 0, "09000064805b976a"], ["FDA-1980-N-0038-0549", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:12:19Z", null, 0, 0, "09000064805b9769"], ["FDA-1980-N-0038-0548", "FDA", "FDA-1980-N-0038", "Order from FDA", "Other", "Order", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:11:33Z", null, 0, 0, "09000064805b9768"], ["FDA-1980-N-0038-0543", "FDA", "FDA-1980-N-0038", "Motion from Ciba-Geigy Corporation", "Other", "Motion", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-02-14T16:11:15Z", null, 0, 0, "09000064805b9739"], ["FDA-1980-N-0038-0553", "FDA", "FDA-1980-N-0038", "Stipulation to Extend Time for Response to Exhibit C-32 from FDA CDER (Sutherland, Asbill & Brennan)", "Other", "Stipulation(s)", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:45:10Z", null, 0, 0, "09000064805b976d"], ["FDA-1980-N-0038-0552", "FDA", "FDA-1980-N-0038", "Drugs for Human Use; Drug Efficacy Study Implementation; Certain Topical Anti-Infective Drug Products; Withdrawal of Approval of New Drug Applications", "Notice", "Withdrawal", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:43:49Z", "85-19803", 0, 0, "09000064805b976c"], ["FDA-1980-N-0038-0551", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:43:02Z", null, 0, 0, "09000064805b976b"], ["FDA-1980-N-0038-0546", "FDA", "FDA-1980-N-0038", "Reply to Motion from FDA CDER", "Other", "Reply", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:08:03Z", null, 0, 0, "09000064805b9766"], ["FDA-1980-N-0038-0541", "FDA", "FDA-1980-N-0038", "Certificate of Service from FDA", "Other", "Certificate of Service", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T15:01:01Z", null, 0, 0, "09000064805b9763"], ["FDA-1980-N-0038-0554", "FDA", "FDA-1980-N-0038", "Order from FDA", "Other", "Order", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T16:46:46Z", null, 0, 0, "09000064805b976e"], ["FDA-1980-N-0038-0540", "FDA", "FDA-1980-N-0038", "Order from  FDA", "Other", "Order", "2018-01-30T05:00:00Z", 2018, 1, null, null, "2018-01-30T14:56:49Z", null, 0, 0, "09000064805b9762"]], "truncated": false, "filtered_table_rows_count": 483, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1980-N-0038", "p1": "2018"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018", "results": [{"value": "FDA", "label": "FDA", "count": 483, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018", "results": [{"value": "Other", "label": "Other", "count": 349, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 121, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018", "results": [{"value": 2018, "label": 2018, "count": 483, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_facet_date=last_modified"}], "next": "2018-01-30T05~3A00~3A00Z,FDA-1980-N-0038-0540", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1980-N-0038&posted_year=2018&_next=2018-01-30T05~3A00~3A00Z%2CFDA-1980-N-0038-0540&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 744.1257750615478, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}